Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade

Luca Perico; Ariela Benigni; Giuseppe Remuzzi

doi:10.1159/000507305

Abstract

1 min read

Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.

Related publications

Letter2020

Reply to the Comment by Dr. Cure on “Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade”

Luca Perico, Ariela Benigni, Giuseppe Remuzzi

Article2021

COVID-19 and the Kidney: Should Nephrologists Care about COVID-19 rather than Maintaining Their Focus on Renal Patients?

Norberto Perico, Luca Perico, Claudio Ronco, Giuseppe Remuzzi

Article2022

Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis

Konstantinos Evangelou, Dimitris Veroutis, Koralia Paschalaki, Periklis Foukas, Nefeli Lаgopati, Marios Dimitriou, Angelos Papaspyropoulos, Bindu Konda, Orsalia Hazapis, Aikaterini Polyzou, Sophia Havaki, Athanassios Kotsinas, Christos Kittas, Athanasios G. Tzioufas, Laurence de Leval, Demetris Vassilakos, Sotirios Tsiodras, Barry R. Stripp, Argyris Papantonis, Giovanni Blandino, Ioannis Karakasiliοtis, ,

Article2022

Inhaled corticosteroids for the treatment of COVID-19

Mona Bafadhel, Rosa Faner, Camille Taillé, Richard Russell, Tobias Welte, Peter J Barnes, Àlvar Agustí

Article2022

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal

Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Mubarak Alruwaili, Raed AlRuwaili, Sarah Albogami, Mohammed Alorabi, ‏Hebatallah M. Saad, Jesus Simal Gandara

Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade

Abstract

Discussion(0)

Related publications

Reply to the Comment by Dr. Cure on “Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade”

COVID-19 and the Kidney: Should Nephrologists Care about COVID-19 rather than Maintaining Their Focus on Renal Patients?

Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis

Inhaled corticosteroids for the treatment of COVID-19

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal